Biochemical basis for the toxic effects of triethyl lead.
D000109:Acetylcholine / Q000378:metabolism; D000818:Animals; D002395:Catecholamines / Q000037:antagonists & inhibitors* / Q000378:metabolism; D002800:Cholinesterase Inhibitors / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D002802:Cholinesterases / Q000097:blood / Q000378:metabolism; D003964:Diaphragm / Q000187:drug effects / Q000201:enzymology; D004285:Dogs; D004576:Electromyography; D007082:Ileum / Q000187:drug effects; D066298:In Vitro Techniques; D007854:Lead / Q000494:pharmacology*; D009119:Muscle Contraction / Q000187:drug effects; D009130:Muscle, Smooth / Q000187:drug effects; D009638:Norepinephrine / Q000494:pharmacology; D009942:Organometallic Compounds / Q000494:pharmacology*; D011220:Pralidoxime Compounds / Q000494:pharmacology; D051381:Rats; D013390:Succinylcholine / Q000494:pharmacology; D009435:Synaptic Transmission / Q000187:drug effects; D013997:Time Factors
D002395:Catecholamines; D002800:Cholinesterase Inhibitors; D009942:Organometallic Compounds; D011220:Pralidoxime Compounds; D007854:Lead; D002802:Cholinesterases; D013390:Succinylcholine; D000109:Acetylcholine; D009638:Norepinephrine